Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Tempus AI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Tempus AI's regulatory disclosures and financial reporting.
Belcher Eric D reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Eric D. Belcher reported an equity compensation grant and his updated shareholdings. He received a grant of 5,913 shares of Class A common stock in the form of restricted stock units at a price of $0.00 per share. These RSUs vest in full on the earlier of the company’s 2027 annual stockholder meeting (or immediately before it if his board service ends at that meeting) or on May 21, 2027, subject to his continuous service. Following the grant, he holds 21,424 Class A shares directly and 14,033 shares indirectly through Nob Hill Ventures LLC, where he has sole investment control and economic interest.
West Nadja reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI director Nadja West received a grant of 5,913 Class A common shares in the form of restricted stock units. This is a compensation-related award with no cash paid by West, and it increases her direct holdings to 37,981 shares after the grant.
The RSUs will vest in full on the earlier of the company’s 2027 annual meeting of stockholders (or immediately before that meeting if her board service ends then) or on May 21, 2027. Vesting is conditioned on her continuous service with Tempus AI through the applicable vesting date.
Leonsis Theodore reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Theodore Leonsis reported an equity compensation grant and his current share holdings. He received an award of 5,913 shares of Class A Common Stock in the form of restricted stock units at a stated price of $0.00 per share, increasing his direct holdings to 21,424 shares. The RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, subject to his continued service as a director. In addition, an indirect position of 66,756 Class A Common Stock shares is reported as held by the Theodore J. Leonsis Revocable Trust.
Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Scott Gottlieb reported receiving an equity award of 5,913 shares of Class A common stock in the form of restricted stock units. These RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, subject to his continuous service. Following this grant, he holds 40,749 shares directly.
Frederick Wayne A.I. reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Frederick Wayne A.I. received an award of 5,913 shares of Class A Common Stock in the form of restricted stock units. These RSUs carry no purchase price and will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, if he remains in continuous service. Following this equity award, his direct holdings reported in this filing total 30,749 shares of Class A Common Stock.
Epstein David R reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI director David R. Epstein received an award of 5,913 shares of Class A common stock in the form of restricted stock units. The award was granted at no cash cost per share and increased his directly held position to 31,714 shares.
The RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting (or immediately before it if his board service ends then) or on May 21, 2027, assuming he continues serving the company through the vesting date.
Doudna Jennifer A reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Jennifer A. Doudna reported receiving an equity compensation grant in the form of 5,913 shares of Class A common stock as a restricted stock unit (RSU) award. The filing shows she now holds 28,615 shares directly after this grant.
The RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting (or immediately before it if her board service ends then) or on May 21, 2027, provided she continues serving as a director through the applicable vesting date. This is a routine, non-cash director compensation award rather than an open-market share purchase or sale.
BARRIS PETER J reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Peter J. Barris received an equity award equivalent to 5,913 shares of Class A Common Stock in the form of restricted stock units. These RSUs will vest in full on the earlier of the company’s 2027 annual stockholders meeting or May 21, 2027, if he remains in continuous service. Following this grant, he directly holds 121,424 shares.
Tempus AI, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 21, 2026. Stockholders, with Class A shares carrying one vote and Class B shares 30 votes per share, elected nine directors to serve until the 2027 annual meeting.
Stockholders also ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 262,396,207 votes for, 90,662 against and 65,045 abstentions. In an advisory vote on how often to hold say-on-pay votes, 191,972,032 votes favored a three-year frequency, compared with 42,744,443 for one year. The board determined future advisory votes on named executive officer compensation will be held every three years.
Tempus AI, Inc. executive Thomas Edward Schoenherr, CEO of Diagnostics, reported a small mandated share sale tied to tax withholding. He sold 1,580 shares of Class A common stock in an open-market transaction at a weighted average price of $44.07 per share. The sale covered statutory tax obligations from vesting restricted stock units under the company’s equity incentive plans and was not a discretionary trade. After this transaction, he directly holds 107,029 shares.